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Abstract—MicroRNAs are a family of small, non-coding
RNAs that regulate gene expression in a sequence-speciﬁc
manner. We propose a computational method to predict miRNA
regulatory modules or groups of miRNAs and target genes that
are believed to participate cooperatively in post-transcriptional
gene regulation. We tested our method with the human genes
and miRNAs, predicting 431 miRNA regulatory modules. The
validations of predicted modules with the literature and Gene
Ontology show that the genes in the modules appear to be closely
related in speciﬁc biological processes, such as gene regulation
involved in various cancers.
I. INTRODUCTION
MicroRNAs (miRNAs) are a novel class of gene products
that repress mRNA translation or mediate mRNA degrada-
tion in a sequence-speciﬁc manner in animals and plants
[1], [2]. Hundreds of different miRNAs have now been
identiﬁed in complex eukaryotes, implying that they mediate
a vast network of unappreciated regulatory interactions [3].
Normally, multiple miRNAs regulate one message, reﬂecting
cooperative translational control. Conversely, one miRNA
may have several target genes, indicative of target multiplic-
ity [2]. This multiplicity of targets and cooperative signal
integration on target genes are key features of the control of
translation by miRNAs [4].
In this study, we mathematically formulate biological
observations on the interactions of miRNAs and their targets
and present a way to identify important patterns hidden in
the complex interactions. Especially, we propose a computa-
tional method that can predict miRNA regulatory modules
(MRMs) or groups of miRNAs and their targets that are
believed to participate cooperatively in post-transcriptional
gene regulation. The proposed method was tested with the
human miRNAs and genes, identifying 431 human MRMs.
Some of the results obtained from this experiment will be
presented in this paper.
Predicted miRNA regulatory modules can be useful for
the reconstruction of gene regulatory networks. That is,
the regulatory interactions newly revealed by MRMs may
provide a missing piece in the puzzle of gene regulation
mechanisms, enabling us to reverse-engineer more accurate
gene regulatory networks. In addition, the genes included in
MRMs can be reasonable candidates for the experimental
validation of miRNA targets, since these genes are detected
multiple times by distinct miRNAs.
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Section II provides the formal deﬁnition of miRNA reg-
ulatory modules and presents an algorithm to predict them.
In Section III, we show our experimental results, focusing
on the analysis of a predicted module through a literature
review and annotation with Gene Ontology (GO) [5].
II. METHOD
The input to our method is the human miRNA and gene
sequences. The output are miRNA regulatory modules. The
method consists of the following steps, and each step will
be detailed in this section.
1) Pre-processing: target genes for each miRNA are iden-
tiﬁed (Section II-A).
2) Relation graph representation: interactions between
miRNAs and their targets are represented by a data
structure called relation graph (Section II-B).
3) Seed ﬁnding: a seed or a set of miRNAs that bind
a common target with similar binding strength is
identiﬁed (Section II-C).
4) Merging seeds: the seeds found are collected and
merged to produce candidates for miRNA regulatory
modules (Section II-D).
5) Post-processing: statistically signiﬁcant miRNA regu-
latory modules are selected by computing the p-value
[6] or the probability of ﬁnding a module by chance
(Section II-E).
A. Pre-processing: identiﬁcation of miRNA target sites
We identify individual miRNA-mRNA duplexes by the
method described in [4] and [7]. Target selection is guided
by the miRNA sequence [3]. Unlike plant miRNAs, animal
miRNAs do not generally exhibit extensive complementarity
to any endogenous transcripts. Thus, most algorithms to
identify animal miRNA targets rely on three properties: (i)
sequence complementarity using a position-weighted local
alignment algorithm, (ii) free energies of miRNA-target
duplexes, and (iii) evolutionary conservation of target sites
in homologous genes.
We refer to the local alignment score and the free energy
of a miRNA-target duplex as sA and sE , respectively. The
scores sA and sE are (negatively) correlated in most cases,
because a duplex with a high local alignment score tends to
have a low free energy and vice versa.
Various conﬁgurations for miRNA-target duplexes are
possible. In particular, when multiple binding sites exist on
a target, the strength of each binding is not too strong or
weak but modest and similar [3]. This observation will be
reﬂected in our mathematical formulation in Section II-B.
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B. Relation graph representation
Based upon the results obtained in the pre-processing step,
we can represent the many-to-many relationships between
miRNAs and target genes by a data structure termed relation
graph, which is deﬁned as follows.
Deﬁnition 1: Let M denote a set of miRNAs and T a set
of targets (typically |M |  |T |). The relation graph is a
weighted bipartite graph G = (V,E,w) with the vertex set
V = M ∪ T , the edge set E = {{m, t}|miRNA m ∈ M
binds target t ∈ T}, and the weight function w : E → R.
In the deﬁnition, the weight function w is determined by
performing Principal Component Analysis (PCA) [8] on the
space spanned by sA and sE .
A miRNA regulatory module is modeled by a biclique
or a complete subgraph in the relation graph. In particular,
we search only those bicliques in which, for each target
vertex t, the edges incident on t have similar weights,
following the biological observation explained in Section II-
A. Furthermore, to avoid redundancy, we ﬁnd only maximal
bicliques that are not contained by other bicliques as a proper
subgraph.
For set A on R, let range(A) denote the absolute dif-
ference between the largest and the smallest elements of A.
Then, we formally deﬁne a miRNA regulatory module as
follows.
Deﬁnition 2: Let G = (M∪T,E,w) be the relation graph
and τ ≥ 0 be given as a parameter. Graph G′ = (M ′ ∪
T ′, E′, w) is called a miRNA regulatory module (MRM),
if G′ is a maximal biclique in G, and for each t ∈ T ′,
range({w|w = w({m, t}), ∀m ∈ M ′}) ≤ τ .
C. Finding seeds
After having constructed the relation graph, we ﬁnd seeds
for each target gene. A seed is formally deﬁned as follows.
Deﬁnition 3: Let t be a target gene and Mt be a set of
miRNAs that binds the target gene t. A seed for t, denoted by
St, is a subset of Mt such that (i) range(St) ≤ τ , and (ii)
there is no M ′ ⊃ St such that M ′ ⊆ Mt and range(M ′) ≤
τ .
Algorithm 1 presents our approach to generate a seed for
a given target transcript. The key idea of this algorithm is
simple: when the elements of set A are sorted and arranged
in the corresponding order, range(A) is simply the absolute
difference between the ﬁrst and the last elements of A. In
Lines 1–6, miRNAs are therefore sorted in ascending order
by their binding strength to the target. In order to keep track
of the ﬁrst and the last elements, two variables begin and end
are maintained in Lines 7–17. The while loop in Lines 8–17
is (i) to handle multiple instances of the seed for a single
target and (ii) to ﬁnd only maximal seeds. The worst-case
complexity of the algorithm is polynomial in |Mt|.
D. Deriving MRMs from seeds
We collect all the seeds found in the previous step and
derive MRMs from this collection of seeds. To store and
manage seeds in a systematic and effective manner, we
exploit the trie, a compact data structure to represent sets
Algorithm 1: Find seeds for each target gene
input : t, target transcript
input : Mt, set of all miRNAs binding t
input : τ , threshold
output: St ⊆ Mt, seed for target t
i := 1;1
foreach m ∈ Mt do2
s[i].w := w(t,m);3
s[i].id := m;4
i := i + 1;5
sort array s in ascending order with respect to the w ﬁeld;6
begin := 1; end := 2;7
while (end ≤ |Mt|) do8
if (s[end].w − s[begin].w ≤ τ) then9
end := end + 1;10
if (end > |Mt|) then11
Report St = {s[begin].id, . . . , s[end− 1].id};12
else13
Report St = {s[begin].id, . . . , s[end− 1].id};14
repeat15
begin := begin + 1;16
until (begin = end) or (s[end].w − s[begin].w ≤ τ);17
of character strings [9]. The seeds are stored in the nodes
of the trie and then merged to form MRMs as the trie is
traversed.
Algorithm 2 details our approach. In addition to the seeds
found by Algorithm 1, Algorithm 2 takes as input two
parameters, minT and minM , to specify the minimum size
of MRMs to ﬁnd.
In Lines 2–6, each seed is inserted into a trie. To decide
the location of the node into which a seed is inserted, we
ﬁrst assume a total order among the elements of M (the set
of all miRNAs in Deﬁnition 1). For each seed St of target t,
we then sort its elements with respect to this total order. The
sorted seed can now be inserted into the node whose path is
speciﬁed by the ordered elements.
To keep track of the seeds and associated target genes
represented by the trie efﬁciently, two sets n.S and n.T are
associated with each node n, as seen in Lines 5–6. Suppose
Algorithm 2: Find miRNA regulatory modules from the seeds
input : All the seeds generated by Algorithm 1
input : minT , the minimum number of target genes in MRMs
input : minM , the minimum number of miRNAs in MRMs
output: miRNA regulatory modules
/* Represent seeds by a trie */1
foreach seed St do2
Sort the elements in St;3
n := the node whose path is speciﬁed by sorted St;4
n.T := n.T ∪ {t};5
n.S := St;6
/* Merge the seeds */7
foreach node n in the post-order traversal of the trie do8
foreach node n′ s.t. |n′.S| = |n.S| − 1 ≥ minM do9
n′.T := n′.T ∪ n.T ;10
/* Prune the trie and collect candidates */11
foreach node n in the pre-order traversal of the trie do12
if |n.S| ≥ minM then13
if |n.T | < minT then14
Remove n and its subtrie rooted at n;15
else16
Collect (n.T, n.S) as a candidate MRM;17
Return maximal candidates as MRMs;18
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that St, a seed for target t, is inserted into node n. Then the
set n.S stores St proper, and the set n.T contains the target
gene t. Later in Line 10, the set n.T will be expanded in
such a way that n.T = {t′ ∈ T |n.S ⊆ St′}.
In Lines 8–10, the algorithm expands the trie to system-
atically merge the seeds and ﬁnd candidates for MRMs. For
each node n encountered in the post-order traversal of the
trie, the set n.T is distributed to every node n′ in which
|n′.M | = |n.M | − 1 and |n′.M | ≥ minM . The node n′ is a
node such that the number of elements in n′.S is one smaller
than n but not less than minM .
In Lines 14–15, every node n in which |n.T | < minT
is deleted. This step can be performed efﬁciently by a pre-
order traversal of the trie. Target genes were distributed in
post-order in Lines 8–10. Consequently, node n in the trie
always has a superset of the genes its children have. Thus,
if the node n has less than minT target genes, then none of
its children can have more. For this reason, we can safely
remove the entire subtree whose root is located at the node
n without visiting its child nodes.
In Lines 17–18, candidates for MRMs are collected, and
the maximal ones are returned as MRMs.
The problem of enumerating maximal bicliques is in-
herently intractable [10], and the worst-case complexity of
Algorithm 2 is exponential in the number of miRNAs in the
relation graph. However, the execution time of the algorithm
on typical benchmarks is practical (see Section III). This
is because a seed seldom contains all the miRNAs in the
relation graph, and the trie-based representation of seeds
helps to prevent unnecessary enumeration of intermediate
results.
E. Post-processing: selecting modules with low p-values
Out of the miRNA regulatory modules found, statistically
signiﬁcant ones are selected. To this end, we estimate the p-
value of an MRM, or the probability of ﬁnding it by chance,
on top of the statistical framework by [11].
We assume that the number of miRNA regulatory modules
with m miRNAs and t targets is a Poisson random variable
denoted by Xm×t. That is,
P (Xm×t = k) =
λke−λ
k!
, k = 0, 1, 2, . . . (1)
The parameter λ corresponds to the average number of the
MRMs with m miRNAs and t targets in the relation graph,
namely,
λ =
(|M |
m
)(|T |
t
)
Pm×t, (2)
where Pm×t is the probability that a random (m × t)
biclique in the relation graph satisﬁes the condition to be
a (m× t) MRM. Based upon the result by [11], Pm×t can
be approximated by
Pm×t 
 ζt[1− ζ]|T |−t[1− (1 + m−1)tτ t]|M |−m, (3)
where
ζ = mτm−1 − (m− 1)τm. (4)
TABLE I
THE PARAMETERS USED FOR THE EXPERIMENT AND SOME STATISTICS
OBTAINED. († THE STANDARD DEVIATION OF THE WEIGHT
DISTRIBUTION.)
Parameters/statistic Value/reference
Parameters (sA cutoff, sE cutoff) (91,−17 kcal/mol)
Parameters (minT ,minM , τ) (3, 3, 2σ† = 2.40)
Size of the relation graph (|T |, |M |, |E|) (2888, 156, 7886)
Total number of modules found 431
Average module size (# targets, # miRNAs) (6.74, 3.58)
The p-value of the MRM with m miRNAs and t targets
is then deﬁned to be the probability that one or more such
MRMs occur by chance in the relation graph, namely,
P (Xm×t ≥ 1) = 1− P (Xm×t = 0) = 1− e−λ. (5)
Finally, we choose those MRMs whose p-value computed
by (5) is less than a certain threshold, highlighting statisti-
cally signiﬁcant modules.
III. EXPERIMENTS
A. Procedure
The proposed method was tested with the human
miRNA sequences (http://www.sanger.ac.uk/Software/Rfam/
mirna) and the human gene sequences (http://www.ensembl.
org/EnsMart). The methods described in [4] and [7] were
ﬁrst used to identify 7,886 human miRNA-mRNA duplexes.
2,888 genes and 156 miRNAs were found to participate in
forming a duplex (see Table I). After the relation graph
was constructed, Algorithms 1 and 2 were invoked with
the parameters listed in Table I. Statistically signiﬁcant
MRMs were selected with the p-value threshold of 0.01.
The tool GO::TermFinder [5] was used to annotate the genes
in selected modules. The computation ran on a 3.06 GHz
Linux machine with 4 GB RAM, and the response time for
Algorithms 1 and 2 was in the order of minutes.
B. Results and validation
431 miRNA regulatory modules were predicted from the
human miRNAs and genes. On average, an MRM consists
of 3.58 miRNAs and 6.74 target genes, as seen in Table I.
Among these predicted modules, here we present a cancer-
related module and analyze it at length. The analysis of the
other modules is omitted due to the space limitation but
can be performed in a similar manner. (A complete list of
the predicted modules is available from the authors upon
request.)
1) Prediction of an oncogenic module: Our data showed
that a set of genes PAK7, BTG2, WT1, PPM1D, and RAB9B
are candidate targets for human miR-15a, miR-16, and miR-
195. Table II lists more details of this module. The ﬁrst
column of the table represents the genes in the module, and
the last three columns show the miRNAs with their binding
strength to each target in terms of the weight calculated by
PCA. The parameters used are listed in Table I. In what
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TABLE II
A PREDICTED HUMAN MIRNA REGULATORY MODULE. († HAS NOT BEEN VERIFIED EXPERIMENTALLY IN HUMAN.)
Target (HUGO ID) Ensemble ID Description hsa-miR-15a hsa-miR-16 hsa-miR-195†
PAK7 ENSG00000101349 p21-activated kinase 7 1.609 -0.789 0.676
RAB9B ENSG00000123570 Ras-associated oncogenic protein 9b 1.303 -0.746 -0.956
BTG2 ENSG00000159388 B cell translocation gene 2 -0.162 -0.816 -1.259
PPM1D ENSG00000170836 protein phosphatase 1D Mg-dependent, delta isoform -0.487 -0.817 -1.143
WT1 ENSG00000184937 Wilms’ tumor 0.275 1.019 -0.514
follows, we consider miR-15a and miR-16 only, since miR-
195 is a predicted miRNA based on homology to a veriﬁed
miRNA from mouse [12], and the expression of this miRNA
has not been veriﬁed in human.
2) Validation with GO: For the genes included in the
module in Table II, the GO terms annotating these genes
repeatedly include GO:0007582 (physiological process),
GO:0008152 (metabolism), GO:0050875 (cellular physiolog-
ical process), GO:0008151 (cell growth and/or maintenance),
and GO:0008283 (cell proliferation). For more quantitative
analysis, we used the tool GO::TermFinder [5] to ﬁnd
signiﬁcantly over-represented GO terms. This tool calculates
a p-value relative to the hypergeometric distribution and also
performs the multiple comparison correction. For example,
Table III presents an enriched GO term for the genes BTG2
and PPM1D and related information.
3) Supporting evidence from the literature: The genes
BTG2, WT1, and PPM1D have been shown to be directly
associated with the function of p53, a tumor suppressor gene
whose activation results in cell cycle arrest and apoptosis
upon DNA damage, viral infection and oncogene activation
[13]. Since inactivation of p53 by deletion or mutation can
cause tumor, it is also possible that the impaired function of
p53 by dysregulation of BTG2, WT1, or PPM1D mediated
by miR-15a and miR-16 might develop tumor in an indirect
way.
Several lines of evidence suggest that miRNAs may be
related with leukemia and other cancers. For example, the
human miR-15a and miR-16 are clustered within 0.5 kb on
chromosome 13q14, and this region has been shown to be
deleted in B cell chronic lymphocytic leukemia (B-CLL),
mantle cell lymphoma, multiple myeloma, and prostate can-
cer cases [14]–[16]. A recent study by [16] demonstrated
that miR-15a and miR-16 are located within a 30-kb region
of loss in CLL, and both genes are deleted or down-regulated
TABLE III
ENRICHED GO TERM OBTAINED BY THE TOOL GO::TERMFINDER [5].
Item Value
GO ID GO:0008285
Term Negative regulation of cell proliferation
p-value 0.000259
Corrected p-value 0.0184
Annotated Genes BTG2, PPM1D
Genome frequency of use 134 out of 23531 genes
in more than two thirds of CLL cases, strongly suggesting
the involvement of miRNA genes in human cancers.
Given that miR-15a and miR-16 are detected together and
found to regulate a set of genes that are actively involved
in tumorigenesis by the use of our method, further studies
should be focused on elucidating the direct role of miR-15a
and miR-16 in many types of cancer through dysregulation
of their target gene expression.
IV. CONCLUSION
We developed a computational method to predict a module
of miRNA and targets. This method was tested with the hu-
man genome and identiﬁed biologically meaningful miRNA
regulatory modules.
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